Latest News from: University of Texas MD Anderson Cancer Center

Filters close
Released: 20-Nov-2024 5:00 PM EST
MD Anderson Receives Nearly $8 Million in CPRIT Funding for Screening and Early Detection Programs, Faculty Recruitment
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today was awarded nearly $8 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of faculty recruitment as well as lung and colorectal cancer screening and early detection programs to address cancer incidence rates across Texas.

   
Newswise: Healthy Women Have Cells That Resemble Breast Cancer, Study Finds
20-Nov-2024 11:00 AM EST
Healthy Women Have Cells That Resemble Breast Cancer, Study Finds
University of Texas MD Anderson Cancer Center

A new study from researchers at The University of Texas MD Anderson Cancer Center finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities typically associated with invasive breast cancer. The findings question conventional thinking on the genetic origins of breast cancer, which could influence early cancer detection methods. The study, published today in Nature, discovered that at least 3% of normal cells from breast tissue in 49 healthy women contain a gain or loss of chromosomes, a condition known as aneuploidy, and that they expand and accumulate with age. This poses questions for our understanding of “normal” tissues, according to principal investigator Nicholas Navin, Ph.D., chair of Systems Biology.

   
Released: 9-Nov-2024 6:00 PM EST
MD Anderson Research Highlights: SITC 2024 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Newswise:Video Embedded md-anderson-launches-institute-for-cell-therapy-discovery-innovation-to-deliver-transformational-new-therapies
VIDEO
Released: 8-Nov-2024 12:00 PM EST
MD Anderson launches Institute for Cell Therapy Discovery & Innovation to deliver transformational new therapies
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and research expertise to lead the world in developing and advancing impactful cell therapies for patients in need.

Newswise: 20241106_Brown_Foundation_Award_106.jpg
Released: 6-Nov-2024 5:50 PM EST
Brown Foundation Award for Excellence in Oncology Nursing honors Tiffany Richards
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today honored Tiffany Richards, Ph.D., A.P.R.N., A.N.P.-B.C., A.O.C.N.P., with the 2024 Brown Foundation Award for Excellence in Oncology Nursing.

Newswise: Jennifer Bickel, M.D., Named MD Anderson Vice President and Chief Wellness Officer
Released: 1-Nov-2024 9:10 AM EDT
Jennifer Bickel, M.D., Named MD Anderson Vice President and Chief Wellness Officer
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution’s inaugural vice president and chief wellness officer (CWO). She will begin on January 6, 2025. Working closely with the senior vice president of people, culture and infrastructure, as well as the chief academic officer, she will spearhead initiatives that prioritize employee well-being, professional fulfillment and community resilience.

Newswise: Quitting Smoking After Cancer Diagnosis Improves Survival Across a Wide Variety of Cancers
30-Oct-2024 2:00 PM EDT
Quitting Smoking After Cancer Diagnosis Improves Survival Across a Wide Variety of Cancers
University of Texas MD Anderson Cancer Center

Smokers who are diagnosed with cancer now have more incentive to quit, as researchers from The University of Texas MD Anderson Cancer Center have found survival outcomes were optimized when patients quit smoking within six months of their diagnosis.

Released: 30-Oct-2024 12:00 PM EDT
MD Anderson Research Highlights for October 30, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Newswise: Combining Targeted Therapy and Immunotherapy Improves Overall Survival in Patients with Anaplastic Thyroid Cancer
24-Oct-2024 11:00 AM EDT
Combining Targeted Therapy and Immunotherapy Improves Overall Survival in Patients with Anaplastic Thyroid Cancer
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in patients with anaplastic thyroid carcinoma (ATC).

Newswise: MD Anderson Expands Arts Experience Program to Enhance Healing and Well-Being for Patients
Released: 23-Oct-2024 2:00 PM EDT
MD Anderson Expands Arts Experience Program to Enhance Healing and Well-Being for Patients
University of Texas MD Anderson Cancer Center

As part of its ongoing commitment to patient comfort and healing, The University of Texas MD Anderson Cancer Center today announced a new focus on art to support the revitalization and expansion of its clinical facilities. This initiative will include the creation of a multisensory healing environment in both public spaces and patient care areas that are designed to prevent disease, promote health and foster well-being.

Released: 16-Oct-2024 12:00 PM EDT
MD Anderson Research Highlights for October 16, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Released: 14-Oct-2024 5:20 PM EDT
Allison Institute Scientific Symposium Features Spatial Biology Breakthroughs, $5 Million Gift to Support Further Efforts
University of Texas MD Anderson Cancer Center

The James P. Allison Institute at The University of Texas MD Anderson Cancer Center hosted its second annual scientific symposium on Oct. 10. The symposium, with more than 900 attendees, featured two Nobel laureates and a $5 million gift from the David and Eula Wintermann Foundation to advance the work of the Allison Institute.

Newswise: Dual Immunotherapy Plus Chemotherapy Benefits Specific Subset of Patients with Lung Cancer
9-Oct-2024 9:00 AM EDT
Dual Immunotherapy Plus Chemotherapy Benefits Specific Subset of Patients with Lung Cancer
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor genes were more likely to benefit from adding the immunotherapy tremelimumab to a combination of durvalumab plus chemotherapy to overcome treatment resistance typically seen in this patient population.

Newswise: MD Anderson and UICC Collaborate to Improve Women's Cancer Care
Released: 8-Oct-2024 9:05 AM EDT
MD Anderson and UICC Collaborate to Improve Women's Cancer Care
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today announced an agreement to become a Women’s Cancer Partner with the Union for International Cancer Control (UICC), marking a significant collaboration to improve breast and cervical cancer care worldwide.

Released: 2-Oct-2024 12:00 PM EDT
MD Anderson Research Highlights for October 2, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Released: 27-Sep-2024 6:05 PM EDT
MD Anderson Research Highlights Special Edition: ASTRO 2024
University of Texas MD Anderson Cancer Center

This special edition features advances in radiation therapy approaches presented by MD Anderson researchers at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting. Information on all MD Anderson ASTRO Annual Meeting content can be found at MDAnderson.org/ASTRO.

Newswise: MD Anderson Launches First-Ever Academic Journal: Advances in Cancer Education & Quality Improvement
Released: 27-Sep-2024 3:05 PM EDT
MD Anderson Launches First-Ever Academic Journal: Advances in Cancer Education & Quality Improvement
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today announced its first-ever academic journal, Advances in Cancer Education & Quality Improvement (ACE-QI). The journal will publish research, training program summaries and quality improvement interventions for the oncology provider community.

   
Newswise: RogersAward2024.jpg
Released: 27-Sep-2024 11:05 AM EDT
Michael Frumovitz, M.D., Posthumously Honored with Julie and Ben Rogers Award for Excellence
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center has posthumously awarded Michael Frumovitz, M.D., with the Julie and Ben Rogers Award for Excellence in Patient Care. The annual award recognizes employees who consistently demonstrate excellence in their work and dedication to MD Anderson’s mission to end cancer.

Released: 19-Sep-2024 12:00 PM EDT
MD Anderson Research Highlights for September 19, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
17-Sep-2024 1:30 PM EDT
Novel Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia
University of Texas MD Anderson Cancer Center

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) – including both accelerated or myeloid blast phases of the disease – or Philadelphia chromosome-positive acute myeloid leukemia (AML) achieved a bone marrow remission when treated with a novel combination of decitabine, venetoclax and ponatinib.



close
0.14448